Ligand-induced Vascular Endothelial Growth Factor Receptor-3 (VEGFR-3) Heterodimerization with VEGFR-2 in Primary Lymphatic Endothelial Cells Regulates Tyrosine Phosphorylation Sites

This publication has 27 references indexed in Scilit:

• Modulation of VEGFR-2–mediated endothelial-cell activity by VEGF-C/VEGFR-3
  Blood, 2003
• Lymphangiogenic Gene Therapy With Minimal Blood Vascular Side Effects
  The Journal of Experimental Medicine, 2002
• Lymphatic endothelial regulation, lymphoedema, and lymph node metastasis
  Seminars in Cell & Developmental Biology, 2002
• VEGFR‐3 in adult angiogenesis
  The Journal of Pathology, 2001
• VEGF‐C and VEGF‐D expression in neuroendocrine cells and their receptor, VEGFR‐3, in fenestrated blood vessels in human tissues
  The FASEB Journal, 2000
• VEGFR-3 and Its Ligand VEGF-C Are Associated with Angiogenesis in Breast Cancer
  The American Journal of Pathology, 1999
• Increased mitogenicity of an αβ heterodimeric PDGF receptor complex correlates with lack of RasGAP binding
  Oncogene, 1999
• Sck Interacts with KDR and Flt-1 via Its SH2 Domain
  Biochemical and Biophysical Research Communications, 1998
• Expression of the Vascular Endothelial Growth Factor C Receptor VEGFR-3 in Lymphatic Endothelium of the Skin and in Vascular Tumors
  The American Journal of Pathology, 1998
• Signal transduction by the PDGF receptors
  Progress in Growth Factor Research, 1994